<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>건강과 대안 &#187; 가짜 인플루엔자 대유행 논란</title>
	<atom:link href="http://www.chsc.or.kr/tag/%EA%B0%80%EC%A7%9C%20%EC%9D%B8%ED%94%8C%EB%A3%A8%EC%97%94%EC%9E%90%20%EB%8C%80%EC%9C%A0%ED%96%89%20%EB%85%BC%EB%9E%80/feed" rel="self" type="application/rss+xml" />
	<link>http://www.chsc.or.kr</link>
	<description>연구공동체</description>
	<lastBuildDate>Mon, 13 Apr 2026 01:34:28 +0000</lastBuildDate>
	<language>ko-KR</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.2</generator>
		<item>
		<title>[돼지독감] 국내 신종플루 사망자 : 총 214명</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=1731</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=1731#comments</comments>
		<pubDate>Tue, 26 Jan 2010 11:54:49 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[식품 · 의약품]]></category>
		<category><![CDATA[가짜 인플루엔자 대유행 논란]]></category>
		<category><![CDATA[돼지독감]]></category>
		<category><![CDATA[신종플루]]></category>
		<category><![CDATA[중앙인플루엔자대책본부]]></category>
		<category><![CDATA[총 214명 사망]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=1731</guid>
		<description><![CDATA[국내 신종플루 사망자 : 총 214명(2010년 1월 16일 현재)출처 : 보건복지부 중앙인플루엔자대책본부http://www.mw.go.kr/front/al/sal0301vw.jsp?PAR_MENU_ID=04&#038;MENU_ID=0403&#038;page=1&#038;BOARD_ID=140&#038;BOARD_FLAG=&#038;CONT_SEQ=225758&#038;SEARCHKEY=&#038;SEARCHVALUE=&#038;CREATE_DATE1=&#038;CREATE_DATE2=&#160;중앙인플루엔자대책본부(본부장:전재희장관)는‘10년 3주차(1.10~1.16) 인플루엔자 유사환자 분율(ILI)이 6.07(잠정치)로 지난주 대비 11.4%, 항바이러스제 처방건수도 27.5%(7,535 ➝ 5,463건) 각각 감소하는 등 [...]]]></description>
				<content:encoded><![CDATA[<p>국내 신종플루 사망자 : 총 214명(2010년 1월 16일 현재)<BR><BR>출처 : 보건복지부 중앙인플루엔자대책본부<BR><A href="http://www.mw.go.kr/front/al/sal0301vw.jsp?PAR_MENU_ID=04&#038;MENU_ID=0403&#038;page=1&#038;BOARD_ID=140&#038;BOARD_FLAG=&#038;CONT_SEQ=225758&#038;SEARCHKEY=&#038;SEARCHVALUE=&#038;CREATE_DATE1=&#038;CREATE_DATE2">http://www.mw.go.kr/front/al/sal0301vw.jsp?PAR_MENU_ID=04&#038;MENU_ID=0403&#038;page=1&#038;BOARD_ID=140&#038;BOARD_FLAG=&#038;CONT_SEQ=225758&#038;SEARCHKEY=&#038;SEARCHVALUE=&#038;CREATE_DATE1=&#038;CREATE_DATE2</A>=<BR><BR>&nbsp;중앙인플루엔자대책본부(본부장:전재희장관)는‘10년 3주차(1.10~1.16) 인플루엔자 유사환자 분율(ILI)이 6.07(잠정치)로 지난주 대비 11.4%, 항바이러스제 처방건수도 27.5%(7,535 ➝ 5,463건) 각각 감소하는 등 하향세가 지속되고 있다고 밝혔다.<A name="[문서의 처음]"></A><br />
<P style="FONT-SIZE: 15pt; MARGIN: 13px 0px 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '휴먼명조'; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: 0px; TEXT-ALIGN: justify">□ 신종플루 환자 중 합병증 입원 사례 현황</SPAN><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: 0px; TEXT-ALIGN: justify">(1.16 기준)</SPAN> </P><br />
<P style="FONT-SIZE: 15pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '휴먼명조'; TEXT-ALIGN: justify"><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: 0px; TEXT-ALIGN: justify">&nbsp;○</SPAN><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: 0px; TEXT-ALIGN: justify"> </SPAN><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify">총 30</SPAN><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify">명이</SPAN><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify"> 중증 합병증</SPAN><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify">으로</SPAN><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify"> 중환자실 입원 중</SPAN> </P><br />
<P style="FONT-SIZE: 15pt; MARGIN: 0px 0px 0px 44px; COLOR: #000000; TEXT-INDENT: -44px; LINE-HEIGHT: 160%; FONT-FAMILY: '휴먼명조'; TEXT-ALIGN: justify"><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: 0px; TEXT-ALIGN: justify">&nbsp;○ 신종플루 관련 </SPAN><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify">사망사례</SPAN><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 15pt; COLOR: #ff0000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify"> </SPAN><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify">5건 </SPAN><SPAN style="FONT-SIZE: 15pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: justify">추가 : 총 214건</SPAN> </P><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px 0px 0px 44px; COLOR: #000000; TEXT-INDENT: -44px; LINE-HEIGHT: 160%; FONT-FAMILY: '휴먼명조'; LETTER-SPACING: -1px; TEXT-ALIGN: right"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: 휴먼명조,한컴돋움; LETTER-SPACING: -1px; TEXT-ALIGN: right">(단위:명)</SPAN> </P><br />
<P style="FONT-SIZE: 16pt; MARGIN: 0px 0px 0px 79px; COLOR: #000000; TEXT-INDENT: -79px; LINE-HEIGHT: 150%; FONT-FAMILY: '한양신명조'; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 16pt; COLOR: #000000; LINE-HEIGHT: 32px; FONT-FAMILY: 한양신명조,한컴돋움; LETTER-SPACING: 0px; TEXT-ALIGN: justify"><A name=#4e552197></A></SPAN><br />
<TABLE style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse" height=89 cellSpacing=0 cellPadding=6 width=639 border=1><br />
<TBODY><br />
<TR><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=91 bgColor=#ffffff height=56 rowSpan=2><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">총 사망자</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=124 bgColor=#ffffff colSpan=2 height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">성 별</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=422 bgColor=#ffffff colSpan=7 height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">연 령 별</SPAN></P></TD></TR><br />
<TR><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=62 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center">남</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=62 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: -3px; TEXT-ALIGN: center">여</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=54 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">0-9</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=66 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">10-19</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">20-29</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">30-39</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">40-49</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">50-59</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=66 bgColor=#ffffff height=28><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">60이상</SPAN></P></TD></TR><br />
<TR><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=91 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">214</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=62 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">114</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=62 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">100</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=54 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">14</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=66 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">6</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">8</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">13</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">18</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=58 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">35</SPAN></P></TD><br />
<TD style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" vAlign=center width=66 bgColor=#ffffff height=32><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '굴림'; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '굴림'; LETTER-SPACING: 0px; TEXT-ALIGN: center">120</SPAN></P></TD></TR></TBODY></TABLE><SPAN></SPAN></P><br />
<P style="FONT-SIZE: 10pt; MARGIN: 0px; COLOR: #000000; TEXT-INDENT: 0px; LINE-HEIGHT: 160%; FONT-FAMILY: '한컴바탕'; TEXT-ALIGN: justify"><SPAN style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 21px; FONT-FAMILY: '한컴바탕'; LETTER-SPACING: 0px; TEXT-ALIGN: justify"><SPAN style="FONT-SIZE: larger"><SPAN style="FONT-FAMILY: Arial"><FONT size=5><SPAN lang=EN-US style="mso-hansi-font-family: HCI Poppy; mso-fareast-font-family: 휴먼명조"></SPAN></FONT></SPAN></SPAN></SPAN>&nbsp;</P></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=1731/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>[돼지독감] 전세계 신종플루 사망자 14142명 (WHO)</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=1708</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=1708#comments</comments>
		<pubDate>Sat, 23 Jan 2010 13:48:30 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[식품 · 의약품]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[가짜 인플루엔자 대유행 논란]]></category>
		<category><![CDATA[돼지독감]]></category>
		<category><![CDATA[신종플루]]></category>
		<category><![CDATA[전세계 사망자 14142명]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=1708</guid>
		<description><![CDATA[세계보건기구가 2010년 1월 20일자 [2009 H1N1 인플루엔자 대유행-업데이트 84]에서 2010년 1월 17일까지 집계된 전세계 신종플루 사망자가 최소한 1만4천1백42명이라고 밝혔습니다. Pandemic (H1N1) 2009 &#8211; update 84 Weekly update 22 [...]]]></description>
				<content:encoded><![CDATA[<p>세계보건기구가 2010년 1월 20일자 [2009 H1N1 인플루엔자 대유행-업데이트 84]에서 2010년 1월 17일까지 집계된 전세계 신종플루 사망자가 최소한 1만4천1백42명이라고 밝혔습니다.<BR><BR><br />
<H1 class=storyPage>Pandemic (H1N1) 2009 &#8211; update 84</H1><br />
<H3 class=sectionHead2>Weekly update</H3><br />
<P>22 January 2010 &#8212; </SPAN><SPAN>As of 17 January 2010, worldwide more than 209 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including at least 14142 deaths. </SPAN></P><br />
<P><SPAN>WHO is actively monitoring the progress of the pandemic through frequent consultations with the WHO Regional Offices and member states and through monitoring of multiple sources of information.</SPAN></P><br />
<H3 class=sectionHead3>Situation update: </H3><br />
<P><SPAN>The overall situation in largely unchanged since last week. The most intense transmission of pandemic influenza virus continues to occur in North Africa, South Asia, and in limited areas of Eastern Europe. Overall pandemic influenza activity in the temperate northern hemisphere peaked between late October and late November 2009 and has continued to decline since. </SPAN></P><br />
<P><SPAN>In North Africa, limited data suggest that transmission of pandemic influenza virus remains geographically widespread and active throughout the region, but has likely recently peaked in most places. During early January 2010 only the Libyan Arab Jamahiriya reported an increasing trend in respiratory diseases activity. Egypt is now reporting a declining trend after increases in respiratory diseases activity throughout December 2009, suggesting a recent peak in activity during early January 2010. In West Asia, limited data suggests pandemic influenza virus transmission remains geographically widespread however overall activity has been declining in most places during December and January. </SPAN></P><br />
<P><SPAN>In South Asia, active transmission of pandemic influenza virus persists in the northern and western parts of the subcontinent, however overall activity has recently peaked. In India, influenza activity has been largely confined to the northern and western states; activity in the northern states peaked during mid December 2009 and in the western states during early January 2010. In Nepal, active transmission of virus persists, and the trend in respiratory diseases activity remains unchanged since the previous week after reporting continuous increases in activity since late October 2009. </SPAN></P><br />
<P><SPAN>In Europe, pandemic influenza virus transmission remains geographically widespread across parts of western, central, and southeastern Europe, however overall influenza activity continued to decline or remain low in most countries The areas of most intense transmission currently include Poland, Austria, Estonia, Romania, Hungary, and Moldova; however, in all but Romania, ILI activity has declined significantly since peaking in November. The overall rate of specimens testing positive for influenza fell to 20% in Europe after reaching a peak of 45% during early November 2009. Pandemic H1N1 2009 virus continues to be predominant circulating influenza virus in the European region with only sporadic detections of seasonal influenza viruses.</SPAN></P><br />
<P><SPAN>In East Asia, pandemic influenza activity remains widespread but continues to decline in most places. Mongolia reported a very high intensity of respiratory diseases during early January 2010; rates of ILI have been elevated above expected seasonal levels since late October 2009 but are well below a significant peak of activity observed during November 2009. In Japan, overall influenza activity continued to decline since peaking at the end of November 2009, however regional increases in activity were observed during late December on the southern island of Okinawa. In China, Hong Kong SAR, and Chinese Taipei pandemic influenza activity remains widespread but continues to decline or remain stable. Pandemic H1N1 continues to be the predominant circulating virus in the region but seasonal H3N2 viruses continue to circulate in very small numbers in northern China.</SPAN></P><br />
<P><SPAN>In the Americas, both in the tropical and northern temperate zones, overall pandemic influenza activity continued to decline or remain low in most places.</SPAN></P><br />
<P><SPAN>In temperate regions of the southern hemisphere, sporadic cases of pandemic influenza continued to be reported without evidence of sustained community transmission. </SPAN></P><br />
<P><SPAN>The Global Influenza Surveillance Network (GISN) continues monitoring the global circulation of influenza viruses, including pandemic, seasonal and other influenza viruses infecting, or with the potential to infect, humans including seasonal influenza. For more information on virological surveillance and antiviral resistance please see the weekly virology update (Virological surveillance data, below). </SPAN></P><A href="http://www.who.int/entity/csr/disease/swineflu/laboratory22_01_2010/en/index.html">Weekly update (Virological surveillance data)</A><br />
<P><SPAN>*Countries in temperate regions are defined as those north of the Tropic of Cancer or south of the Tropic of Capricorn, while countries in tropical regions are defined as those between these two latitudes. <BR><BR>**Abbreviations: influenza-like-illness (ILI), acute respiratory infection (ARI), and severe acute respiratory infection (SARI) </SPAN></P><br />
<H3 class=sectionHead2>Qualitative indicators (Week 29 to Week 1: 13 July 2009 &#8211; 10 January 2010)</H3><br />
<P><SPAN>The qualitative indicators monitor: the global geographic spread of influenza, trends in acute respiratory diseases, the intensity of respiratory disease activity, and the impact of the pandemic on health-care services. </SPAN></P><A href="http://www.who.int/entity/csr/resources/publications/swineflu/interim_guidance/en/index.html">Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance</A><BR>A description of WHO pandemic monitoring and surveillance objectives and methods can be found in the updated interim WHO guidance for the surveillance of human infection with pandemic (H1N1) virus. <BR><BR><br />
<P><SPAN>The maps below display information on the qualitative indicators reported. Information is available for approximately 60 countries each week. Implementation of this monitoring system is ongoing and completeness of reporting is expected to increase over time. </SPAN></P><A href="http://www.who.int/entity/csr/resources/publications/influenza/interim_guidance_definitions/en/index.html">List of definitions of qualitative indicators</A><br />
<H3 class=sectionHead3>Geographic spread of influenza activity</H3><A href="http://gamapserver.who.int/h1n1/qualitative_indicators/atlas.html?indicator=i0&#038;date=Week 01 (04-Jan-2010 : 10-Jan-2010)" target=_new>Map timeline</A><br />
<H3 class=sectionHead3>Trend of respiratory diseases activity compared to the previous week</H3><A href="http://gamapserver.who.int/h1n1/qualitative_indicators/atlas.html?indicator=i1&#038;date=Week 01 (04-Jan-2010 : 10-Jan-2010)" target=_new>Map timeline</A><br />
<H3 class=sectionHead3>Intensity of acute respiratory diseases in the population </H3><A href="http://gamapserver.who.int/h1n1/qualitative_indicators/atlas.html?indicator=i2&#038;date=Week 01 (04-Jan-2010 : 10-Jan-2010)" target=_new>Map timeline</A><br />
<H3 class=sectionHead3>Impact on health care services</H3><A href="http://gamapserver.who.int/h1n1/qualitative_indicators/atlas.html?indicator=i3&#038;date=Week 01 (04-Jan-2010 : 10-Jan-2010)" target=_new>Map timeline</A><br />
<H3 class=sectionHead3>Laboratory-confirmed cases of pandemic (H1N1) 2009 as officially reported to WHO by States Parties to the IHR (2005) as of 10 January 2010</H3><A href="http://gamapserver.who.int/h1n1/cases-deaths/h1n1_casesdeaths.html" target=_new>Map of affected countries and deaths</A><br />
<P><SPAN>The countries and overseas territories/communities that have newly reported their first pandemic (H1N1) 2009 confirmed cases since the last web update (No. 83): Mali.</SPAN></P><br />
<P><SPAN>The countries and overseas territories/communities that have newly reported their first deaths among pandemic (H1N1) 2009 confirmed cases since the last web update (No. 83): none. </SPAN></P><br />
<P><SPAN><br />
<TABLE class=MsoNormalTable style="MARGIN-LEFT: 4.65pt; WIDTH: 414.75pt; BORDER-COLLAPSE: collapse; mso-padding-alt: 5.25pt 5.4pt 5.25pt 5.4pt" cellSpacing=0 cellPadding=0 width=553 border=0><br />
<TBODY><br />
<TR style="HEIGHT: 12.75pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes"><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; BORDER-TOP: black 1pt solid; PADDING-LEFT: 5.4pt; BORDER-BOTTOM-WIDTH: 1pt; BORDER-BOTTOM-COLOR: black; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; PADDING-TOP: 5.25pt; HEIGHT: 12.75pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><B><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">Region</SPAN></B><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial"> </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><?XML:NAMESPACE PREFIX = O /><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; BORDER-TOP: black 1pt solid; PADDING-LEFT: 5.4pt; BORDER-LEFT-WIDTH: 1pt; BORDER-LEFT-COLOR: black; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 12.75pt; mso-border-top-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">Deaths* </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 12.75pt; mso-yfti-irow: 1"><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; BORDER-TOP: black 1pt solid; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 12.75pt; mso-border-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">&nbsp; </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT-STYLE: none; HEIGHT: 12.75pt; mso-border-right-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt" vAlign=bottom noWrap width=156><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">&nbsp; </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 25.5pt; mso-yfti-irow: 2"><br />
<TD style="BORDER-TOP-WIDTH: 1pt; BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; BORDER-TOP-COLOR: black; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 25.5pt; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">WHO Regional Office for <?XML:NAMESPACE PREFIX = ST1 /><ST1:PLACE w:st="on">Africa</ST1:PLACE> (AFRO) </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; BORDER-LEFT-STYLE: none; HEIGHT: 25.5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana">131<O:P> </O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 25.5pt; mso-yfti-irow: 3"><br />
<TD style="BORDER-TOP-WIDTH: 1pt; BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; BORDER-TOP-COLOR: black; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 25.5pt; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">WHO Regional Office for the <ST1:COUNTRY-REGION w:st="on"><ST1:PLACE w:st="on">Americas</ST1:PLACE> </ST1:COUNTRY-REGION>(AMRO) </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; BORDER-LEFT-STYLE: none; HEIGHT: 25.5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">At least 7094 </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 25.5pt; mso-yfti-irow: 4"><br />
<TD style="BORDER-TOP-WIDTH: 1pt; BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; BORDER-TOP-COLOR: black; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 25.5pt; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">WHO Regional Office for the <ST1:PLACE w:st="on">Eastern Mediterranean</ST1:PLACE> (EMRO) </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; BORDER-LEFT-STYLE: none; HEIGHT: 25.5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana">941<O:P> </O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 24pt; mso-yfti-irow: 5"><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; HEIGHT: 24pt; BORDER-BOTTOM-STYLE: none; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">WHO Regional Office for <ST1:PLACE w:st="on">Europe</ST1:PLACE> (EURO) </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-LEFT-STYLE: none; HEIGHT: 24pt; BORDER-BOTTOM-STYLE: none; mso-border-right-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">At least 3099 </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 25.5pt; mso-yfti-irow: 6"><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; BORDER-TOP: black 1pt solid; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 25.5pt; mso-border-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">WHO Regional Office for <ST1:PLACE w:st="on">South-East Asia</ST1:PLACE> (SEARO) </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; BORDER-TOP: black 1pt solid; PADDING-LEFT: 5.4pt; BORDER-LEFT-WIDTH: 1pt; BORDER-LEFT-COLOR: black; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 25.5pt; mso-border-top-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana">1366<O:P> </O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 25.5pt; mso-yfti-irow: 7"><br />
<TD style="BORDER-TOP-WIDTH: 1pt; BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; BORDER-TOP-COLOR: black; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 25.5pt; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">WHO Regional Office for the Western Pacific (WPRO) </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; BORDER-LEFT-STYLE: none; HEIGHT: 25.5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana">1511<O:P> </O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 12.75pt; mso-yfti-irow: 8"><br />
<TD style="BORDER-TOP-WIDTH: 1pt; BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; BORDER-TOP-COLOR: black; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; HEIGHT: 12.75pt; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">&nbsp; </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: black 1pt solid; BORDER-LEFT-STYLE: none; HEIGHT: 12.75pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid black .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">&nbsp; </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD></TR><br />
<TR style="HEIGHT: 12.75pt; mso-yfti-irow: 9; mso-yfti-lastrow: yes"><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; BORDER-LEFT: black 1pt solid; WIDTH: 297.75pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 12.75pt; mso-border-left-alt: solid black .5pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid windowtext .5pt" vAlign=bottom width=397><br />
<P class=MsoNormal style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">Total*</SPAN><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana"> </SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P></O:P></SPAN></P></TD><br />
<TD style="BORDER-RIGHT: black 1pt solid; PADDING-RIGHT: 5.4pt; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 5.25pt; WIDTH: 117pt; BORDER-TOP-STYLE: none; PADDING-TOP: 5.25pt; BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT-STYLE: none; HEIGHT: 12.75pt; mso-border-right-alt: solid black .5pt; mso-border-bottom-alt: solid windowtext .5pt" vAlign=bottom width=156><br />
<P class=MsoNormal style="TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" align=center><SPAN style="FONT-SIZE: 10pt; COLOR: black; FONT-FAMILY: Verdana; mso-bidi-font-family: Arial">At least 14142</SPAN><SPAN style="FONT-SIZE: 8.5pt; COLOR: black; FONT-FAMILY: Verdana"><O:P> </O:P></SPAN></P></TD></TR></TBODY></TABLE></SPAN></P><br />
<P><SPAN>* The reported number of fatal cases is an under representation of the actual numbers as many deaths are never tested or recognized as influenza related.</SPAN></P></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=1708/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
